Publications by authors named "Debora Ferrarotti"
Biomedicines
January 2023
Article Synopsis
- This study aimed to identify HCV-positive patients with advanced chronic liver disease (aCLD) who can skip hepatocellular carcinoma (HCC) surveillance after successful treatment with Direct Acting Antiviral Agents (DAAs).
- The researchers divided 1,000 patients into four groups based on liver stiffness measurement and fibrosis scores, then tracked their HCC development over a median follow-up of 48 months.
- The findings revealed that approximately 90% of patients in the lowest risk group had negligible HCC incidence, indicating that certain scores could help assess who needs ongoing surveillance after achieving a sustained viral response.
